{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:43:45Z","timestamp":1772934225808,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Ment Health"],"DOI":"10.1007\/s44192-026-00408-5","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:19:28Z","timestamp":1772860768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The combination of exercise and psychedelics for the treatment of major depressive disorder"],"prefix":"10.1007","volume":"6","author":[{"given":"Nicholas","family":"Fabiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Carhart-Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"12346","DOI":"10.1038\/s41598-024-62381-9","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Liu Y, Ma W, Tong Y, Zheng J. Temporal and spatial trend analysis of all-cause depression burden based on Global Burden of Disease (GBD) 2019 study. Sci Rep. 2024;14:12346.","journal-title":"Sci Rep"},{"key":"408_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"W Marx","year":"2023","unstructured":"Marx W, Penninx BWJH, Solmi M, Furukawa TA, Firth J, Carvalho AF, et al. Major depressive disorder. Nat Rev Dis Primer. 2023;9:44.","journal-title":"Nat Rev Dis Primer"},{"key":"408_CR3","doi-asserted-by":"crossref","unstructured":"Zhou C, Puder D, Fabiano N. How to prescribe physical activity for depression. Sports Psychiatry. 2024.","DOI":"10.1024\/2674-0052\/a000099"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/jamapsychiatry.2022.0609","volume":"79","author":"M Pearce","year":"2022","unstructured":"Pearce M, Garcia L, Abbas A, Strain T, Schuch FB, Golubic R, et al. Association between physical activity and risk of depression: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79:550\u2013559.","journal-title":"JAMA Psychiatry"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1123\/jpah.2024-0743","volume":"22","author":"N Fabiano","year":"2025","unstructured":"Fabiano N, Puder D, Stubbs B. The evidence is clear, exercise is not better than antidepressants or therapy: it is crucial to communicate science honestly. J Phys Act Health. 2025;22:161\u2013162.","journal-title":"J Phys Act Health"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"E596","DOI":"10.1503\/cmaj.231288","volume":"196","author":"C Zhou","year":"2024","unstructured":"Zhou C, Fabiano N. Exercise as a treatment for depression. CMAJ Can Med Assoc J J Assoc Medicale Can. 2024;196:E596\u201396.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bjsports-2022-106282","volume":"57","author":"A Heissel","year":"2023","unstructured":"Heissel A, Heinen D, Brokmeier LL, Skarabis N, Kangas M, Vancampfort D, et al. Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression. Br J Sports Med. 2023;57:1049\u201357.","journal-title":"Br J Sports Med"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eurpsy.2018.07.004","volume":"54","author":"B Stubbs","year":"2018","unstructured":"Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, et al. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and position statement from the european psychiatric association (EPA), supported by the international organization of physical therapists in mental health (IOPTMH). Eur Psychiatry J Assoc Eur Psychiatr. 2018;54:124\u201344.","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"RW Lam","year":"2024","unstructured":"Lam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: R\u00e9seau canadien pour les traitements de l\u2019humeur et de l\u2019anxi\u00e9t\u00e9 (CANMAT) 2023 : Mise \u00e0 jour des lignes directrices cliniques pour la prise en charge du trouble d\u00e9pressif majeur chez les adultes. Can J Psychiatry Rev Can Psychiatr. 2024;69:641\u201387.","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"408_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2025-110405","author":"N Fabiano","year":"2025","unstructured":"Fabiano N, Puder D, Stubbs B. Could not prescribing exercise for depression be psychiatric malpractice? Br J Sports Med. 2025. https:\/\/doi.org\/10.1136\/bjsports-2025-110405. 9 September 2025.","journal-title":"Br J Sports Med"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jad.2023.02.071","volume":"330","author":"N Fabiano","year":"2023","unstructured":"Fabiano N, Gupta A, Fiedorowicz JG, Firth J, Stubbs B, Vancampfort D, et al. The effect of exercise on suicidal ideation and behaviors: a systematic review and meta-analysis of randomized controlled trials. J Affect Disord. 2023;330:355\u201366.","journal-title":"J Affect Disord"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"105547","DOI":"10.1016\/j.neubiorev.2024.105547","volume":"158","author":"N Fabiano","year":"2024","unstructured":"Fabiano N, Gupta A, Wong S, Tran J, Mohammad IY, Bal S, et al. Physical activity, suicidal ideation, suicide attempt and death among individuals with mental or other medical disorders: A systematic review of observational studies. Neurosci Biobehav Rev. 2024;158:105547.","journal-title":"Neurosci Biobehav Rev"},{"key":"408_CR13","first-page":"43","volume":"4","author":"N Fabiano","year":"2025","unstructured":"Fabiano N. Is exercise a form of self-harm? Sports Psychiatry J Sports Exerc Psychiatry. 2025;4:43\u20134.","journal-title":"Sports Psychiatry J Sports Exerc Psychiatry"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jad.2023.02.064","volume":"329","author":"JE Verhoeven","year":"2023","unstructured":"Verhoeven JE, Han LKM, Lever-van Milligen BA, Hu MX, R\u00e9v\u00e9sz D, Hoogendoorn AW, et al. Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders. J Affect Disord. 2023;329:19\u201329.","journal-title":"J Affect Disord"},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpsychires.2025.12.025","volume":"194","author":"AO Werneck","year":"2026","unstructured":"Werneck AO, Tian X, Lu W, Li D, Liu T, Wu S, et al. Can exercise reduce the risk of suicidal ideation and behaviors in youth at school? A 12 month cluster randomized control trial. J Psychiatr Res. 2026;194:71\u20138.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"408_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1123\/jpah.2025-0501","volume":"23","author":"C Robinson-Ethier","year":"2025","unstructured":"Robinson-Ethier C, Stubbs B, Fabiano N. Physical activity in suicide prevention: beyond the potential, there is a need for nuanced implementation and research. J Phys Act Health. 2025;23(1):3\u20134. . https:\/\/doi.org\/10.1123\/jpah.2025-0501","journal-title":"J Phys Act Health"},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Goodwin GM. The Therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2017;42:2105\u201313.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"115531","DOI":"10.1016\/j.psychres.2023.115531","volume":"329","author":"S Haikazian","year":"2023","unstructured":"Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, et al. Psilocybin-assisted therapy for depression: a systematic review and meta-analysis. Psychiatry Res. 2023;329:115531.","journal-title":"Psychiatry Res"},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, et al. Trial of psilocybin versus escitalopram for depression. N Engl J Med. 2021;384:1402\u201311.","journal-title":"N Engl J Med"},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euroneuro.2025.09.011","volume":"101","author":"M H\u00f8jlund","year":"2025","unstructured":"H\u00f8jlund M, Kafali HY, K\u0131rm\u0131z\u0131 B, Fusar-Poli P, Correll CU, Cortese S, et al. Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: a living systematic review with meta-analysis. Eur Neuropsychopharmacol. 2025;101:41\u201355.","journal-title":"Eur Neuropsychopharmacol"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"204512532513724","DOI":"10.1177\/20451253251372449","volume":"15","author":"S Wong","year":"2025","unstructured":"Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, et al. Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis. Ther Adv Psychopharmacol. 2025;15:20451253251372449.","journal-title":"Ther Adv Psychopharmacol"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","volume":"367","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc B Biol Sci. 2012;367:2475\u201384.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1139\/apnm-2018-0192","volume":"43","author":"JJ Walsh","year":"2018","unstructured":"Walsh JJ, Tschakovsky ME. Exercise and circulating BDNF: Mechanisms of release and implications for the design of exercise interventions. Appl Physiol Nutr Metab Physiol Appl Nutr Metab. 2018;43:1095\u2013104.","journal-title":"Appl Physiol Nutr Metab Physiol Appl Nutr Metab"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","volume":"26","author":"R Moliner","year":"2023","unstructured":"Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci. 2023;26:1032\u201341.","journal-title":"Nat Neurosci"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/brainsci9050112","volume":"9","author":"PD Loprinzi","year":"2019","unstructured":"Loprinzi PD, Zou L, Li H. The endocannabinoid system as a potential mechanism through which exercise influences episodic memory function. Brain Sci. 2019;9:112.","journal-title":"Brain Sci"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1007\/s00018-014-1575-6","volume":"71","author":"M Tantimonaco","year":"2014","unstructured":"Tantimonaco M, Ceci R, Sabatini S, Catani MV, Rossi A, Gasperi V, et al. Physical activity and the endocannabinoid system: an overview. Cell Mol Life Sci CMLS. 2014;71:2681\u201398.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","volume":"48","author":"AE Calder","year":"2023","unstructured":"Calder AE, Hasler G. Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology. 2023;48:104\u201312.","journal-title":"Neuropsychopharmacology"},{"key":"408_CR28","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1073\/pnas.1015950108","volume":"108","author":"KI Erickson","year":"2011","unstructured":"Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108:3017\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.biopsych.2015.11.022","volume":"80","author":"A Colasanti","year":"2016","unstructured":"Colasanti A, Guo Q, Giannetti P, Wall MB, Newbould RD, Bishop C, et al. Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple Sclerosis. Biol Psychiatry. 2016;80:62\u201372.","journal-title":"Biol Psychiatry"},{"key":"408_CR30","first-page":"1157","volume":"238","author":"JS Siegel","year":"2021","unstructured":"Siegel JS, Palanca BJA, Ances BM, Kharasch ED, Schweiger JA, Yingling MD, et al. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. Psychopharmacology. 2021;238:1157\u201369.","journal-title":"Psychopharmacology"},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","volume":"632","author":"JS Siegel","year":"2024","unstructured":"Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, et al. Psilocybin desynchronizes the human brain. Nature. 2024;632:131\u20138.","journal-title":"Nature"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hipo.23169","volume":"30","author":"CA Kronman","year":"2020","unstructured":"Kronman CA, Kern KL, Nauer RK, Dunne MF, Storer TW, Schon K. Cardiorespiratory fitness predicts effective connectivity between the hippocampus and default mode network nodes in young adults. Hippocampus. 2020;30:526\u201341.","journal-title":"Hippocampus"},{"key":"408_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/brainsci11070829","volume":"11","author":"A Marques","year":"2021","unstructured":"Marques A, Marconcin P, Werneck AO, Ferrari G, Gouveia \u00c9R, Kliegel M, et al. Bidirectional association between physical activity and dopamine across adulthood\u2014a systematic review. Brain Sci. 2021;11:829.","journal-title":"Brain Sci"},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"1257629","DOI":"10.3389\/fpubh.2023.1257629","volume":"11","author":"J Tyler","year":"2023","unstructured":"Tyler J, Podaras M, Richardson B, Roeder N, Hammond N, Hamilton J, et al. High intensity interval training exercise increases dopamine D2 levels and modulates brain dopamine signaling. Front Public Health. 2023;11:1257629.","journal-title":"Front Public Health"},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-physiol-042022-020923","volume":"86","author":"CJ Hatzipantelis","year":"2024","unstructured":"Hatzipantelis CJ, Olson DE. The effects of psychedelics on neuronal physiology. Annu Rev Physiol. 2024;86:27\u201347.","journal-title":"Annu Rev Physiol"},{"key":"408_CR36","doi-asserted-by":"publisher","first-page":"104800","DOI":"10.1016\/j.neubiorev.2022.104800","volume":"140","author":"LA Jelen","year":"2022","unstructured":"Jelen LA, Stone JM, Young AH, Mehta MA. The opioid system in depression. Neurosci Biobehav Rev. 2022;140:104800.","journal-title":"Neurosci Biobehav Rev"},{"key":"408_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17756\/jrdsas.2017-036","volume":"3","author":"T Archer","year":"2017","unstructured":"Archer T, Badgaiyan RD, Blum K. Physical exercise interventions for drug addictive disorders. J Reward Defic Syndr Addict Sci. 2017;3:17\u201320.","journal-title":"J Reward Defic Syndr Addict Sci"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00018-024-05519-2","volume":"82","author":"A Pulido-Saavedra","year":"2025","unstructured":"Pulido-Saavedra A, Oliva HNP, Prudente TP, Kitaneh R, Nunes EJ, Fogg C, et al. Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies. Cell Mol Life Sci CMLS. 2025;82:49.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1177\/0269881111420188","volume":"25","author":"KA MacLean","year":"2011","unstructured":"MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol Oxf Engl. 2011;25:1453\u201361.","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0269881117731279","volume":"32","author":"RR Griffiths","year":"2018","unstructured":"Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol Oxf Engl. 2018;32:49\u201369.","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"408_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/acps.12904","volume":"138","author":"D Erritzoe","year":"2018","unstructured":"Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, et al. Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand. 2018;138:368\u201378.","journal-title":"Acta Psychiatr Scand"},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3389\/fpsyt.2019.00955","volume":"10","author":"A Garcia-Romeu","year":"2019","unstructured":"Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW. Persisting reductions in cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: an online survey. Front Psychiatry. 2019;10:955.","journal-title":"Front Psychiatry"},{"key":"408_CR43","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881119845793","volume":"33","author":"A Garcia-Romeu","year":"2019","unstructured":"Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. J Psychopharmacol (Oxf). 2019;33:1088\u2013101.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/02791072.2019.1567961","volume":"51","author":"G Ona","year":"2019","unstructured":"Ona G, Kohek M, Massaguer T, Gomariz A, Jim\u00e9nez DF, Dos Santos RG, et al. Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual Ayahuasca users. J Psychoact Drugs. 2019;51:135\u2013145.","journal-title":"J Psychoact Drugs"},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/02791072.2022.2077155","volume":"55","author":"M Kohek","year":"2023","unstructured":"Kohek M, Ona G, van Elk M, Dos Santos RG, Hallak JEC, Alc\u00e1zar-C\u00f3rcoles M\u00c1, et al. Ayahuasca and public health II: health status in a large sample of Ayahuasca-ceremony participants in the Netherlands. J Psychoact Drugs. 2023;55:247\u2013258.","journal-title":"J Psychoact Drugs"},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/psychoactives2040017","volume":"2","author":"D Perkins","year":"2023","unstructured":"Perkins D, Opaleye E, Bouso JC, T\u00f3foli LF, Sarris J, Schubert V, et al. Insights, life changes and lifestyle changes reported by individuals consuming Ayahuasca in naturalistic settings: nature, frequency and associations with mental health and wellbeing. Psychoactives. 2023;2:256\u2013286.","journal-title":"Psychoactives"},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0022167817709585","volume":"57","author":"R Watts","year":"2017","unstructured":"Watts R, Day C, Krzanowski J, Nutt D, Carhart-Harris R. Patients\u2019 accounts of increased connectedness and acceptance after psilocybin for treatment-resistant depression. J Humanist Psychol. 2017;57:520\u2013564.","journal-title":"J Humanist Psychol"},{"key":"408_CR48","doi-asserted-by":"publisher","first-page":"14427","DOI":"10.1038\/s41598-021-93787-4","volume":"11","author":"O Simonsson","year":"2021","unstructured":"Simonsson O, Osika W, Carhart-Harris R, Hendricks PS. Associations between lifetime classic psychedelic use and cardiometabolic diseases. Sci Rep. 2021;11:14427.","journal-title":"Sci Rep"},{"key":"408_CR49","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/HYPERTENSIONAHA.120.16715","volume":"77","author":"O Simonsson","year":"2021","unstructured":"Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W. Association between lifetime classic psychedelic use and hypertension in the past year. Hypertension. 2021;77:1510\u20136.","journal-title":"Hypertension"},{"key":"408_CR50","doi-asserted-by":"publisher","first-page":"821208","DOI":"10.3389\/fpsyt.2022.821208","volume":"13","author":"EC Neuhaus","year":"2022","unstructured":"Neuhaus EC, Slavich GM. Behavioral psychedelics: integrating mind and behavior to improve health and resilience. Front Psychiatry. 2022;13:821208.","journal-title":"Front Psychiatry"},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"117134","DOI":"10.1016\/j.socscimed.2024.117134","volume":"357","author":"H Kuiper","year":"2024","unstructured":"Kuiper H, Alley C, Harris Z, Kuiper Rauch C, Robbins M, Rodriguez P, et al. Psychedelic public health: State of the field and implications for equity. Soc Sci Med. 2024;357:117134.","journal-title":"Soc Sci Med"},{"key":"408_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcbs.2019.12.004","volume":"15","author":"R Watts","year":"2020","unstructured":"Watts R, Luoma JB. The use of the psychological flexibility model to support psychedelic assisted therapy. J Context Behav Sci. 2020;15:92\u2013102.","journal-title":"J Context Behav Sci"},{"key":"408_CR53","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/ppc.12482","volume":"56","author":"E Y\u0131ld\u0131z","year":"2020","unstructured":"Y\u0131ld\u0131z E. The effects of acceptance and commitment therapy on lifestyle and behavioral changes: a systematic review of randomized controlled trials. Perspect Psychiatr Care. 2020;56:657\u201390.","journal-title":"Perspect Psychiatr Care"},{"key":"408_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/02698811211008554","volume":"36","author":"PJ Teixeira","year":"2022","unstructured":"Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, et al. Psychedelics and health behaviour change. J Psychopharmacol Oxf Engl. 2022;36:12\u20139.","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"408_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1745691612447309","volume":"7","author":"JYY Ng","year":"2012","unstructured":"Ng JYY, Ntoumanis N, Th\u00f8gersen-Ntoumani C, Deci EL, Ryan RM, Duda JL, et al. Self-determination theory applied to health contexts: a meta-analysis. Perspect Psychol Sci. 2012;7:325\u2013340.","journal-title":"Perspect Psychol Sci"},{"key":"408_CR56","doi-asserted-by":"publisher","first-page":"205510292097812","DOI":"10.1177\/2055102920978123","volume":"7","author":"S Gandy","year":"2020","unstructured":"Gandy S, Forstmann M, Carhart-Harris RL, Timmermann C, Luke D, Watts R. The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychol Open. 2020;7:2055102920978123.","journal-title":"Health Psychol Open"},{"key":"408_CR57","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/acsptsci.1c00034","volume":"4","author":"JE Payne","year":"2021","unstructured":"Payne JE, Chambers R, Liknaitzky P. Combining psychedelic and mindfulness interventions: synergies to inform clinical practice. ACS Pharmacol Transl Sci. 2021;4:416\u2013423.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"408_CR58","first-page":"292","volume":"3","author":"T Khazaeinia","year":"2000","unstructured":"Khazaeinia T, Ramsey AA, Tam YK. The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2000;3:292\u2013302.","journal-title":"J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm"},{"key":"408_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/07853899109148062","volume":"23","author":"P Ylitalo","year":"1991","unstructured":"Ylitalo P. Effect of exercise on pharmacokinetics. Ann Med. 1991;23:289\u201394.","journal-title":"Ann Med"},{"key":"408_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2016.07.018","volume":"99","author":"G Taghizadeh","year":"2016","unstructured":"Taghizadeh G, Pourahmad J, Mehdizadeh H, Foroumadi A, Torkaman-Boutorabi A, Hassani S, et al. Protective effects of physical exercise on MDMA-induced cognitive and mitochondrial impairment. Free Radic Biol Med. 2016;99:11\u201319.","journal-title":"Free Radic Biol Med"},{"key":"408_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2015.02.037","volume":"1608","author":"DV Zaretsky","year":"2015","unstructured":"Zaretsky DV, Zaretskaia MV, Durant PJ, Rusyniak DE. Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus. Brain Res. 2015;1608:75\u201381.","journal-title":"Brain Res"}],"container-title":["Discover Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-026-00408-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44192-026-00408-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-026-00408-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:02:47Z","timestamp":1772866967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44192-026-00408-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s44192-026-00408-5","relation":{},"ISSN":["2731-4383"],"issn-type":[{"value":"2731-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BS is on the Editorial Board of the Journal of Physical Activity and Health, Ageing Research Reviews, Mental Health and Physical Activity, The Journal of Evidence Based Medicine, and The Brazilian Journal of Psychiatry. BS has received honorarium from a co-edited book on exercise and mental illness (Elsevier), an associated education course and unrelated advisory work from ASICS and FitXR LTD. JDR has received research grant support from the Canadian Institute of Health Research (CIHR), Physician Services Inc (PSI) Foundation, Labatt Brain Health Network, Brain and Cognition Discovery Foundation (BCDF), Canadian Cancer Society, Canadian Psychiatric Association, Academic Scholars Award, American Psychiatric Association, American Society of Psychopharmacology, University of Toronto, University Health Network Centre for Mental Health, Joseph M. West Family Memorial Fund and Timeposters Fellowship and industry funding for speaker\/consultation\/research fees from iGan, Boehringer Ingelheim, Janssen, Allergan, Lundbeck, Sunovion and COMPASS. He was previously the Chief Medical and Scientific Officer of Braxia Scientific and the medical director of the Canadian Rapid Treatment Centre of Excellence (Braxia Health). PJT is the research director at The Synthesis Institute B.V. MWJ is an advisor to AWAKN Life Sciences Inc., Beckley Psytech Ltd., Entheogen Biomedical Corp., Field Trip Psychedelics Inc., Mind Medicine Inc., Otsuka Pharmaceutical Development & Commercialization Inc., and Silo Pharma, Inc. RC-H reports receiving consulting fees from COMPASS Pathways, Entheon Biomedical, Mydecine, Synthesis Institute, Tryp Therapeutics, and Usona Institute. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}